AI-native platforms are overtaking legacy EMRs because they are built for real-time automation, large language models (LLMs), and rapid change, while most incumbent systems are constrained by 10–20 years of technical debt and rigid architectures. This is no longer a theoretical debate about technology. AI platforms are a direct driver of cost structure and competitive positioning over the next 12–24 months.  The Market Is Splitting into Two  Across healthcare, executives are

The AI divide in post-acute care is already visible: agencies that modernize are eliminating 20–40% of administrative cost and reclaiming thousands of clinical hours , while organizations clinging to legacy EMRs are locking in a structurally higher cost base that will be impossible to sustain. For post-acute care leaders, the core strategic question is no longer whether to adopt AI-native workflows, but how quickly you can re-architect operations before AI-first competitors r

Acquisitions in healthcare technology – especially among EMRs – are common. Vendors expand their offerings, fill capability gaps, or accelerate product roadmaps by purchasing tools rather than building them internally. For post-acute care agencies, these acquisitions can significantly influence daily operations, workflows, costs, and long-term technology planning. This article explains, why these acquisitions happen , how they affect providers , and what they mean during a pe